Literature DB >> 21745523

Preparing for the availability of a partially effective HIV vaccine: some lessons from other licensed vaccines.

Robert T Chen1, Dale J Hu, Eileen Dunne, Michael Shaw, James I Mullins, Supachai Rerks-Ngarm.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21745523      PMCID: PMC4578794          DOI: 10.1016/j.vaccine.2011.07.015

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


× No keyword cloud information.
  69 in total

1.  Calling the shots: immunization finance policies and practices. Executive summary of the report of the Institute of Medicine.

Authors:  B Guyer; D R Smith; R Chalk
Journal:  Am J Prev Med       Date:  2000-10       Impact factor: 5.043

Review 2.  Immunogen sequence: the fourth tier of AIDS vaccine design.

Authors:  James I Mullins; David C Nickle; Laura Heath; Allen G Rodrigo; Gerald H Learn
Journal:  Expert Rev Vaccines       Date:  2004-08       Impact factor: 5.217

3.  HPV vaccination mandates--lawmaking amid political and scientific controversy.

Authors:  James Colgrove; Sara Abiola; Michelle M Mello
Journal:  N Engl J Med       Date:  2010-08-19       Impact factor: 91.245

4.  Human immunodeficiency virus type 1 env evolves toward ancestral states upon transmission to a new host.

Authors:  Joshua T Herbeck; David C Nickle; Gerald H Learn; Geoffrey S Gottlieb; Marcel E Curlin; Laura Heath; James I Mullins
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

5.  Adolescent immunization delivery in school-based health centers: a national survey.

Authors:  Matthew F Daley; C Robinette Curtis; Jennifer Pyrzanowski; Jennifer Barrow; Kathryn Benton; Lisa Abrams; Steven Federico; Linda Juszczak; Paul Melinkovich; Lori A Crane; Allison Kempe
Journal:  J Adolesc Health       Date:  2009-05-30       Impact factor: 5.012

6.  Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolution.

Authors:  Elodie Ghedin; Naomi A Sengamalay; Martin Shumway; Jennifer Zaborsky; Tamara Feldblyum; Vik Subbu; David J Spiro; Jeff Sitz; Hean Koo; Pavel Bolotov; Dmitry Dernovoy; Tatiana Tatusova; Yiming Bao; Kirsten St George; Jill Taylor; David J Lipman; Claire M Fraser; Jeffery K Taubenberger; Steven L Salzberg
Journal:  Nature       Date:  2005-10-05       Impact factor: 49.962

7.  Factors influencing pediatricians' intention to recommend human papillomavirus vaccines.

Authors:  Jessica A Kahn; Susan L Rosenthal; Abbigail M Tissot; David I Bernstein; Caitlin Wetzel; Gregory D Zimet
Journal:  Ambul Pediatr       Date:  2007 Sep-Oct

8.  Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys.

Authors:  Sampa Santra; Hua-Xin Liao; Ruijin Zhang; Mark Muldoon; Sydeaka Watson; Will Fischer; James Theiler; James Szinger; Harikrishnan Balachandran; Adam Buzby; David Quinn; Robert J Parks; Chun-Yen Tsao; Angela Carville; Keith G Mansfield; George N Pavlakis; Barbara K Felber; Barton F Haynes; Bette T Korber; Norman L Letvin
Journal:  Nat Med       Date:  2010-02-21       Impact factor: 53.440

9.  The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies.

Authors:  M J Alter; S C Hadler; H S Margolis; W J Alexander; P Y Hu; F N Judson; A Mares; J K Miller; L A Moyer
Journal:  JAMA       Date:  1990-03-02       Impact factor: 56.272

10.  Coping with viral diversity in HIV vaccine design.

Authors:  David C Nickle; Morgane Rolland; Mark A Jensen; Sergei L Kosakovsky Pond; Wenjie Deng; Mark Seligman; David Heckerman; James I Mullins; Nebojsa Jojic
Journal:  PLoS Comput Biol       Date:  2007-04-27       Impact factor: 4.475

View more
  4 in total

1.  HIV population-level adaptation can rapidly diminish the impact of a partially effective vaccine.

Authors:  Joshua T Herbeck; Kathryn Peebles; Paul T Edlefsen; Morgane Rolland; James T Murphy; Geoffrey S Gottlieb; Neil Abernethy; James I Mullins; John E Mittler; Steven M Goodreau
Journal:  Vaccine       Date:  2017-12-11       Impact factor: 3.641

Review 2.  Stakeholder Engagement in HIV Cure Research: Lessons Learned from Other HIV Interventions and the Way Forward.

Authors:  Ying-Ru Lo; Carissa Chu; Jintanat Ananworanich; Jean-Louis Excler; Joseph D Tucker
Journal:  AIDS Patient Care STDS       Date:  2015-05-18       Impact factor: 5.078

3.  A curative regimen would decrease HIV prevalence but not HIV incidence unless targeted to an ART-naïve population.

Authors:  Dobromir T Dimitrov; Hans-Peter Kiem; Keith R Jerome; Christine Johnston; Joshua T Schiffer
Journal:  Sci Rep       Date:  2016-02-24       Impact factor: 4.379

4.  Are Clade Specific HIV Vaccines a Necessity? An Analysis Based on Mathematical Models.

Authors:  Dobromir Dimitrov; James G Kublin; Scott Ramsey; Lawrence Corey
Journal:  EBioMedicine       Date:  2015-11-05       Impact factor: 8.143

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.